Natural history of untreated HDV patients: Always a progressive disease?

Area of Science:

• Hepatology and Viral Hepatitis Research
• Infectious Diseases Epidemiology
• Gastroenterology

Background:

• Early chronic hepatitis D (CHD) studies indicated a severe disease course, rapid cirrhosis development, and high mortality.
• Epidemiological shifts show decreasing domestic CHD cases and increasing cases among younger immigrants from endemic regions.
• Recent findings reveal a substantial proportion of CHD patients exhibit an indolent disease course.

Purpose of the Study:

• To analyze the evolving epidemiological landscape and clinical spectrum of chronic hepatitis D.
• To identify key predictors of poor clinical outcomes in patients with CHD.
• To highlight the need for further research on the natural history and long-term effects of novel antiviral therapies for CHD.

Main Methods:

• Review of early studies and recent epidemiological data on chronic hepatitis D.
• Analysis of patient demographics, including age, risk factors, and geographic origin.
• Identification of clinical factors associated with disease progression and outcomes.

Main Results:

• At diagnosis, 30%-50% of CHD patients already have established liver cirrhosis.
• Older age, pre-existing liver cirrhosis, HIV co-infection, and lack of interferon therapy predict worse outcomes.
• Novel antiviral treatments are emerging, offering hope due to historically low response rates to existing therapies.

Conclusions:

• The clinical spectrum of chronic hepatitis D is broader than previously thought, including indolent disease courses.
• Key predictors for adverse outcomes in CHD patients include older age, cirrhosis, HIV co-infection, and prior non-response to interferon.
• Further research is crucial to understand the natural history of CHD and evaluate the long-term impact of new antiviral agents.